Werfen

Werfen

As part of our strategy to continue supporting our Partners with the implementation of IT solutions, we are very pleased to release the first HemoHub™ Installation Requirements & Checklist Guide

Diagnostic testing, through accurate results, enables the health care providers in effective delivery of care in today's complex healthcare system, particularly in acute care settings.

On September 17th, World Patient Safety Day, Werfen EEMEAI conducted an educational event that received over 8700 registrations, demonstrating the commitment of EEMEAI colleagues, distribution partners and customers towards Patient Safety, as envisioned by Werfen.

In September, King Faisal Specialty Hospital and Research Center (the hospital) confirmed that all inhouse Thrombotic Thrombocytopenic Purpura (TTP) diagnosing and monitoring will be done with HemosIL AcuStar ADAMTS13 Activity assay in a 2-year deal, that includes a Bio-Flash analyzer for its autoimmunity laboratory.

For the first time, GEMweb Live is in clinical use―at three hospitals in Spain. A real-time onscreen data viewer, GEMweb Live consolidates test results from ROTEM, VerifyNow, Hemochron and GEM Premier systems, at the point of care, all on one screen.

Dear Good Morning EEMEAI readers, 

We are proud of proposing this new issue, the last for 2021, with plenty of engaging articles: from Success Stories to our Corporate Social Responsibility initiatives, from Werfen Academy corner to technical updates on GEM Premier & HemoCell.

Werfen is happy to support the 27th edition in a virtual mode of the International Congress on Thrombosis.

EEMEAI 2021 Half Term Meeting has been the very first in person since January 2020.

16 months ago, before the pandemic spread like wildfire, Milan, Dubai and Russia hubs met in Palermo for the 2020 Kick Off, after that we could no more be in the same place in person altogether.

Pane Quotidiano

Corporate Social Responsibility is a very dear topic to Werfen at corporate and local level.

Werfen hub in Milan is being working on a corporate social responsibility project we are proud of: both EEMEAI and Italy subsidiaries, who share the same HQ, decided to join forces and help regularly one of the oldest Onlus in Milan: Pane Quotidiano – which means “daily bread”.

One of the key aspects of clinical value selling is augmentation of ecosystem and market advocacy in the focus areas. Enablement and empowerment of the end user, in terms of clinical application of Werfen products and solutions, continues to drive clinical marketing strategy.

Page 29 of 41

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top